Toronto, Ontario--(Newsfile Corp. - February 4, 2015) - CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, today announced that it has agreed to issue 50,000 common shares of the Company at a deemed price of $0.10 per share as compensation for $5,000 worth of services provided to Crystal Research Associates, LLC (Crystal Research), New York.
Crystal Research, an independent equity research firm, is working with the CardioComm Solutions in the development of corporate updates of which will highlight the Company’s performance and key accomplishments. The research reports will have distribution through Crystal Research’s investor and finance media communications channels.
The issuance of the shares is subject to the approval of the TSX Venture Exchange and applicable securities laws.
About CardioComm Solutions
CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Ontario, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking statements
This release may contain certain forward-looking statements and forward looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.
In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
copyright (c) newsfile corp. 2015. all rights reserved